12:00 AM
 | 
Oct 05, 2009
 |  BC Week In Review  |  Company News  |  Deals

Advirna, RXi Pharmaceuticals deal

RXi acquired four of Advirna's RNAi delivery technologies for an undisclosed sum. RXi, which exercised an option to license...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >